Jefferies Group's ONC Position Overview
Jefferies Group (via Jefferies Financial Group Inc.) currently holds 6,200 shares of BeOne Medicines AG (ONC) worth $1.88 M, representing 0.01% of the portfolio. First purchased in 2023-Q3, this medium-term investment has been held for 9 quarters.
Based on 13F filings, Jefferies Group has maintained a strategic position in ONC, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2025, adding 6,200 shares. Largest reduction occurred in Q1 2024, reducing 37,957 shares.
Analysis based on 13F filings available since 2013 Q2
Jefferies Group's BeOne Medicines (ONC) Holding Value Over Time
Track share changes against reported price movement
Quarterly BeOne Medicines (ONC) Trades by Jefferies Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +6,200 | New Buy | 6,200 | $303.81 |
| Q3 2025 | -2,900 | Sold Out | 0 | $0.00 |
| Q1 2025 | +900 | Add 45.00% | 2,900 | $272.17 |
| Q4 2024 | +2,000 | New Buy | 2,000 | $184.71 |
| Q2 2024 | -8,043 | Sold Out | 0 | $0.00 |
| Q1 2024 | -37,957 | Reduce 82.52% | 8,043 | $156.39 |
| Q3 2023 | +46,000 | New Buy | 46,000 | $179.87 |
Jefferies Group's BeOne Medicines Investment FAQs
Jefferies Group first purchased BeOne Medicines AG (ONC) in Q3 2023, acquiring 46,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group has held BeOne Medicines AG (ONC) for 9 quarters since Q3 2023.
Jefferies Group's largest addition to BeOne Medicines AG (ONC) was in Q3 2023, adding 46,000 shares worth $8.27 M.
According to the latest 13F filing for Q4 2025, Jefferies Group's firm, Jefferies Financial Group Inc., owns 6,200 shares of BeOne Medicines AG (ONC), valued at approximately $1.88 M.
As of the Q4 2025 filing, BeOne Medicines AG (ONC) represents approximately 0.01% of Jefferies Group's publicly disclosed stock portfolio, making it one of their key holdings.
Jefferies Group's peak holding in BeOne Medicines AG (ONC) was 46,000 shares, as reported at the end of Q3 2023.